Management Dispute Resolved: Court Recommends Settlement, Directors Resign


  • The lawsuit for removal of directors at Dongseong Pharmaceutical (Case No. 2025가합20903) has been concluded via a court-recommended settlement.
  • Under the settlement, two defendant directors (N and W) resigned from their positions, and the plaintiff (Brand Refactoring Co.) abandoned the remaining claims.
  • Each party bears its own litigation costs.
  • Decision date: April 24, 2026; Confirmation date: May 14, 2026 (no objection filed).
  • This follows the initial disclosure of the management dispute lawsuit on Oct 30, 2025; the resolution removes legal uncertainty.
ADVERTISEMENT (250px+)

KOSPI Filing Information


  • Filing: Judgment/Decision on Litigation, etc.
  • Company: Dongsung Pharmaceutical (002210)
  • Submission: Dongsung Pharmaceutical Co., Ltd.
  • Receipt: 05-14-2026
  • Under KRX KOSPI Market Division